July 27, 2018Open Access

Metabolomics Biomarkers for Detection of Colorectal Neoplasms: A Systematic Review

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Panels of metabolites consisting of amino acids in blood and nucleosides in urinary samples might be useful biomarkers for early detection of advanced colorectal neoplasms. However, to make metabolomic biomarkers clinically applicable, future research in larger studies and external validation of the results is required.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Erben et al. (Fri,) studied this question.

synapsesocial.com/papers/69df2b0fd9e0feb21c591e81 https://doi.org/https://doi.org/10.3390/cancers10080246

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Physical activity and risk of colon adenoma: a meta-analysis2011 · 170 citations
2Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection2010 · 143 citations
3Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement2009 · 83,320 citations
4A Machine-Learned Predictor of Colonic Polyps Based on Urinary Metabolomics2013 · 43 citations
5NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer2016 · 129 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo